Luczo, Jasmina M. http://orcid.org/0000-0002-8036-110X
Bousse, Tatiana
Johnson, Scott K.
Jones, Cheryl A.
Pearce, Nicholas
Neiswanger, Carlie A.
Wang, Min-Xuan
Miller, Erin A.
Petrovsky, Nikolai http://orcid.org/0000-0002-1580-5245
Wentworth, David E. http://orcid.org/0000-0002-5190-980X
Bronshtein, Victor
Papania, Mark
Tompkins, Stephen M. http://orcid.org/0000-0002-1523-5588
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400004C, HHSN272201400008C, AI061142, HHSN272200800039C, HHSN272201400053C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM109435)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 3 November 2020
Accepted: 10 March 2021
First Online: 21 April 2021
Competing interests
: V.B. is a principal of Universal Stabilization Technologies, Inc., which holds interests in the Preservation by Vaporization technology, and N.P. is associated with Vaxine Pty Ltd, which holds interests in Advax™ adjuvant. M.P. is an inventor of the dry-powder inhaler, which is patented by CDC and Creare, Inc., and serves on the Scientific Advisory Board of VitriVac, Inc., which holds interests in the Preservation by Vaporization technology.